22:46:56Canada

Nephros, Inc. (NEPH)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
18,789,000 32.7%
Net income
1,194,000 1513.5%
Gross profit
11,625,000
Operating income
1,146,000
Earnings per share
0.11 1000%
R&D expense
1,339,000

Growth and profitability

Gross margin
61.87
Operating margin
6.10
Net margin
6.35
Return on equity
11.70
Return on assets
8.75

Balance sheet

Total assets
13,641,000
Total liabilities
3,439,000
Shareholders' equity
10,202,000
Cash and equivalents
5,400,000
Current ratio
4.06

Cash flow and ratios

Operating cash flow
1,645,000

Shareholder returns

Shares outstanding
10,870,004
Book value per share
0.94
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
South Orange, NJ
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Surgical & Medical Instruments & Apparatus

Fiscal year end: · Source: SEC EDGAR

Nephros, Inc. trades on NASDAQ under the ticker symbol NEPH. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis